dongfang modern agriculture holdinggroup 27 may …...2019/05/27 · supplement (and softgel...
TRANSCRIPT
Dongfang Modern Agriculture Holding Group
Annual General Meeting 27 May 2019
For
per
sona
l use
onl
y
No representation or warranty, express or implied, is made as to the fairness, accuracy,
completeness or correctness of the information, opinions and conclusions contained in the
presentation. To the maximum extent permitted by law, none of Dongfang Modern Agriculture
Holding Group Limited, its directors, employees or agents, nor any other person accepts any
liability, including, without limitation, any liability arising out of fault. In particular, no
representation or warranty, express or implied is given as to the accuracy, completeness or
correctness, likelihood of achievement or reasonableness of any forecasts, prospects or
returns contained in this presentation nor is any obligation assumed to update such
information. Such forecasts, prospects or returns are by their nature subject to significant
uncertainties and contingencies.
Before making an investment decision, you should consider, with or without the assistance of a
financial adviser, whether an investment is appropriate in light of your particular investment needs,
objectives and financial circumstances. Past performance is no guarantee of future performance.
All references to dollars, cents or $ in this presentation are to Australian (AUD) currency,
unless otherwise stated.
Disclaimer
2
For
per
sona
l use
onl
y
Company Snapshot
Summary
ASX code DFM
Last close price $0.84
Market cap. $370m
P/E Ratio 4.3x
*as at 24 May 2019
FY2017 FY2018
Revenue (A$m) 221.8 244.9
NPAT (A$m) 97.5 84.4
EPS (A$) 0.24 0.21
NTA/share (A$) 1.20 1.36
3
For
per
sona
l use
onl
y
Leading manufacturer
of health supplements in
Australia through Bio
Health Pharmaceuticals
TGA and ACO licensed,
GMP manufacturer with
strong customer base
Market leading fruit
harvester within the
world’s largest agricultural
market
Spanning 11,641
hectares of orchards
all located within China’s
premier Ganzhou fruit-
growing region
Highly profitable with
seventh consecutive year
of record harvest production
and revenue growth
Apply modern agricultural
technologies to newly
acquired under performing
assets to achieve 20% to
40% yield improvements
Capitalising on Chinese
consumers’ preference
for healthy fruit products
China’s middle class
increasing from 12% to
22% of the population by
2030
New manufacturing
facility located at
Huntingwood, Sydney
New plant expected to
more than treble
manufacturing capacity
to meet strong customer
demand
Growth strategy through acquisition of orchardsand increased yield, andexpansion of health supplement business.
Benefiting from long term Chinese Government tax incentives
Key Facts
4
For
per
sona
l use
onl
y
Agriculture Business
5
Enjoys all the advantages of being
located within China’s best fruit growing
region
• 23 orchards spanning 11,641 hectares
located in Ganzhou, Jiangxi
• Ganzhou City is a Special Citrus Zone
• “Gannan Navel Orange” is a national top
brand
• High average rain falls ~1500mm p.a.
• Orchards equipped with dripping system
and water tanks
• Long frost-free growing season
• Ganzhou population >9m provides ample
labour force
23orchards
For
per
sona
l use
onl
y
Health Supplement Business
6
Australian based manufacturer of health
supplements
• Founded 2010 with year on year growth
• TGA and ACO licensed, GMP
Manufacturer
• Specialises in manufacture of
complementary medicines, health and skin
care products
• Located in Sydney with existing plant at
Silverwater
• New 4,800 square metre facility located at
Huntingwood, approximately 36 kms from
the Sydney CBD
• Track record for excellence in manufacture
• Strong customer base, including export to
Asia
Insert photo
of outside of
new plant
5 Healey Circuit, Huntingwood, NSW, 2148
For
per
sona
l use
onl
y
Revenue and NPAT
7
Revenue NPAT• Seventh consecutive
record harvest;
includes harvest from
526-hectare camellia
plantation and 354-
hectare navel orange
plantation acquired in
July 2018
• Lower NPAT reflects
lower than expected
productivity of newly-
acquired orchards and
financing costs
associated with
acquisition strategy,
including Bio Health
• Gross margins of 42%
For
per
sona
l use
onl
y
Reported EPS and Dividend
88
Reported earnings per share Dividend*• Lower earnings per
share reflects reduced
NPAT
• In light of the
company’s growth
focus, the board has
decided to reinvest in
the business
• This allows Dongfang
to take advantage of
opportunities in both
the Chinese orchards
and health supplements
markets
• Dividend policy remains
a board focus
For
per
sona
l use
onl
y
Timeline
19 OCT 2015
✭Quotation on ASX
9
31 Dec 2015
✭ Acquisition of 853-ha camellia
plantations ~A$42m
11 MAR 2016
✭ Included in ASX/S&P All Ordinaries Index
31 MAR 2016
✭ Record NPAT of A$90m, beat prospectus
forecast
30 JUN 2016
✭ Acquisition of 400-ha tangerine
and 800-ha camellia for ~A$81m
31 MAR 2017
✭ Record revenue
of A$206m
31 AUG 2017
✭ Announced 2017 interim result
6 JULY 2017
✭ Acquisition of 380-ha camellia plantation and
544-ha navel orange plantation for ~A$94m
3 JAN 2018
✭ Announced A$50m debt facility
28 FEB 2018
✭ Record NPAT of $97.5 million
29 MAR 2019
✭ NPAT of $84.4 million
23 APR 2018
✭ Acquisition of 70% of
Bio Health Pharmaceuticals
2 JUL 2018
✭ Acquisition of 526-ha camellia plantation
and 354-ha navel orange plantation
For
per
sona
l use
onl
y
Revenue Analysis and Production
10
• Total production up from
nearly 240,000 tonnes in
2015 to 284,000 tonnes in
2018
• Further benefits expected
through yield improvements
on newly-acquired orchards
• Tangerines provide about
50% of revenue; due to
acquisitions, camellia and
orange production has
increased and their
revenues now exceed
pomelo revenue
• Health supplement
business expected to grow
after move to new premises
Production by Categories FY2018 Total Revenue Breakdown
For
per
sona
l use
onl
y
Camellia Harvest
11
• Production increase follows acquisition of
526 hectare camellia plantation in
Xingguo County in Ganzhou city region
• Production of 45,550 tonnes in 2018, up
nearly 20% from 37,893 tonnes in 2017;
camellia revenue increased 20% year-
on-year
• Production is mostly processed into
‘heart healthy’ cooking oil which has a
high smoke point
• Dongfang continues to assess
opportunities to expand through
downstream processing of camellia
products for tier-1 markets
Annual production
For
per
sona
l use
onl
y
Tangerine Harvest
12
• Tangerine production of 149.6 million
tonnes in 2018, up from 147.8 million
tonnes in 2017
• Dongfang’s tangerines are known for thin
skin, bright colour and sweet flavour, and
sourced primarily from Xunwu County
• Although Chinese production is
increasing, Dongfang’s high-quality
products maintain good prices
• Unit prices up about 1% compared to
2017
Annual production
For
per
sona
l use
onl
y
Navel Orange Harvest
13
• Record navel orange production of
42,544 tonnes, including production from
the 354-hectare orchard acquired in July
2018, was up 27% on 2017
• Dongfang’s “Gannan” navel oranges are
high-quality, sweet fruit with high juice
content, primarily for eating
• Orchards located in Ganzhou City
Special Citrus Zone
• Smaller orange crops after last year’s
bumper production although unit prices
were stable at RMB 4.99/kg, similar to
last year
• Demand for high-quality branded
oranges continues to grow with the rapid
development of cold storage and cold
chain infrastructure in China
Annual production
For
per
sona
l use
onl
y
Pomelo Harvest
14
• Pomelos are similar to grapefruit, with
white, pink or red flesh
• 2018 harvest of 46,000 tonnes was
about 2% lower than 47,000 tonnes in
2017 due to unseasonable weather
(similar to 2017)
• Unit prices maintained of RMB3.1/kg, on
par with 2017 prices
• The pomelo harvest takes place in
September, October and November
Annual production
For
per
sona
l use
onl
y
Growth Plan – Primary Drivers
15
• Reinvest profit in upstream grower
business, 6% - 9% p.a. plantation area
increase every year through acquisitions
• Improve productivity and yield of orchard
acquisitions 20% - 40% in first three
years by professional management
• Continued focus on achieving efficiencies
and cost reductions; advantages from
larger scale
• Benefit from FTA between China and
Australia
For
per
sona
l use
onl
y
Bio Health Update
16
• Dongfang acquired 70% of Bio Health
Pharmaceuticals Pty Limited in 2018; key
management retained
• Dongfang’s connections and sales network in
China open up export opportunities to
capitalise on the US$41 billion Chinese
health supplements market
• Bio Health is a TGA licence holding health
supplement (and softgel capsule)
manufacturer and Australian Certified
Organic licensed business
• Strong established customer base with
positive reputation for manufacturing high-
quality products
• Strategic move into high margin, high growth
health supplement market broadens
Dongfang’s revenue base
For
per
sona
l use
onl
y
Bio Health Update
17
• Production in 2018 constrained by size
of manufacturing facility
• Dongfang is investing in state-of-the art
equipment and Bio Health’s move to
new site at Huntingwood, Sydney
• New facility will enable tripling of current
production levels; production expected
to begin in second half of 2019
• Unit costs expected to reduce by 5%
due to economies of scale
• Plan allows diversification into health
food pharmaceuticals and development
of own brand labelFor
per
sona
l use
onl
y
Summary
18
• Seven consecutive years of record
harvest production
• Track record of growth and profitability
including 2018 net profit after tax of $84.4
million
• Australian acquisition of Bio Health
provides opportunities to build own brand
in high-margin, high-growth health food
supplements market
• Bio Health is moving to new premises
enabling tripling of production;
manufacturing at Huntingwood, Sydney
expected to begin in second half of 2019
• 35% growth in orchard area over past
three years, reflecting reinvestment in the
business and clear growth strategy
• Continued focus on yield improvement in
Chinese orchards expected to increase
productivity
• Ongoing focus on both organic growth
and acquisition opportunities
• Further revenue growth and profitability
expected in 2019
For
per
sona
l use
onl
y
Contact Us
19
International
Mr Charles So
Chief Executive Officer
Tel: +61 4 4989 5835
Australia
Mr Ashley Rambukwella
Financial & Corporate Relations
Tel: +61 4 0723 1282
For
per
sona
l use
onl
y
Board of Directors / Management
Hongwei Cai
Executive Chairman
Founder and major
shareholder (major
underlying shareholder since
2008)
Extensive experience in
management, marketing
and business development
of agricultural enterprises
Chiu (Charles) So
Chief Executive
Officer
Previously Executive
Director of a Hong Kong
listed Company
18 years’ experience in
accounting and finance
Barton Tso
Executive Director
Previously Executive
Director / Chief Financial
Officer of a Hong Kong listed
Company
28 years’ experience in
enterprise management and
banking business investment
Dan Lin
Non-Executive
Director
PRC government relations
and Australian business
development experience
Significant Chinese
telecommunications industry
experience including as a
council member
Michael Choi
Non-Executive
Director
Former member of
Queensland Parliament
Held various ministerial
portfolios including Mines,
Energy, Natural Resources,
Trade and Multicultural
Affairs
21
For
per
sona
l use
onl
y
Land Title
22
• Dongfang controls 23 plantations spanning
11,641 hectares, located in China’s premier
citrus growing region, the Ganzhou City
district, Jiangxi Province
• Private land ownership is not possible in the
PRC, but individual farmers historically have
been given a right to use the land.
Government has allowed aggregation of
these land usage rights to permit large-scale
intensive farming
• Dongfang has aggregated several
plantations, implementing better operating
practices which increase yield and
productivity
• Lease-hold operation rights purchased from
village committees (co-operatives):
o Lease: right to manage the orchards and
sell the fruit produced, but do not own the
land nor plantations on that land;
o Acquired: own the land and plantations
on that land
o Lease: 15 years; Acquired: 30 years
o Average life remaining for Dongfang
plantations: ~14 years
For
per
sona
l use
onl
y
2018 Financial Results
23
Sound financial
performance
2018 2017
RMB ’000 AUD ’000 RMB ’000 AUD ’000
Revenue 1,173,387 244,887 1,062,767 221,800
Cost of sales (683,975) (142,756) (582,387) (121,545)
Gross profit 489,412 102,141 480,380 100,255
Other income (26,445) (5,519) 1,253 262
Administrative expenses (37,959) (7,922) (14,482) (3,022)
425,008 88,700 467,151 97,495
Finance costs (22,788) (4,756) (12) (3)
Profit before income tax 402,220 83,944 467,139 97,492
Income tax credit 2,203 460 - -
Profit for the year 404,423 84,404 467,139 97,492
Other comprehensive income:
Items that may be subsequently reclassified to profit or loss
Exchange differences on translating foreign operations 16,074 3,355 (10,961) (2,288)
Other comprehensive income for the year, net of tax 16,074 3,355 (10,961) (2,288)
Total comprehensive income for the period 420,497 87,759 456,178 95,204
Profit attributable to:
Owners of the Company 405,176 84,561 467,139 97,492
Non-controlling interest (753) (157) - -
404,423 84,404 467,139 97,492
Earnings per share
Basic RMB0.96 AUD0.21 RMB1.16 AUD0.24
For
per
sona
l use
onl
y
Statement of Financial Position
24
Strong balance sheet
AUD1 = RMB4.791545
As of 31 December 2018
31 Dec 2018
AUD ’000
31 Dec 2017
AUD ’000
Assets
Current
Cash and cash equivalents 82,211 79,719
Trade and other receivables 127,601 112,890
Amount due from shareholder 708 -
Inventory 792 -
Deferred expenses 26,730 21,606
Total current assets 238,043 214,214
Non-current
Goodwill 7,240 -
Intangible assets 18,947 -
Property, plant and equipment 1,392 252
Bearer plant 416,178 340,447
Deposits for capital expenditure 7,510 -
Deferred expenses 10,796 21,592
Total non-current assets 462,063 362,291
Total assets 700,107 576,505
Liabilities
Current
Trade and other payables 39,000 54,723
Amount due to a shareholder - 14,303
Current portion of bank borrowings 5,490 -
Current portion of obligation under finance lease 191 17
Income tax payable 2,129 2,129
Total current liabilities 46,809 71,172
Non-current
Non-current portion of bank borrowings 49,407 -
Non-current portion of obligation under finance lease 507 70
Deferred tax liabilities 5,521 -
Total non-current liabilities 55,435 70
Total liabilities 102,244 71,242
Net assets 597,863 505,263
Equity
Share capital 64,636 64,636
Reserves 17,289 13,679
Retained earnings 511,508 426,948
Equity attributable to owners of the Company 593,433 505,263
Non-controlling interest 4,429 -
Total equity 597,862 505,263
For
per
sona
l use
onl
y
Shareholding
25
Analysis of Holdings as at 28 March 2019
Dongfang Modern Agriculture Holding Group Limited
Securities: Fully Paid ordinary Shares
Holdings Ranges Holders Total Units %
1–1,000 157 62,166 0.015
1,001–5,000 315 758,334 0.180
5,001–10,000 75 558,403 0.133
10,001–100,000 119 3,506,483 0.834
100,000–99,999,999,999 34 415,471,644 98.838
Totals 700 420,356,644 100.000
Holder (as at 15 May 2019) Number of Shares % of CSO Description
Cai, Hongwei (Executive Chairman) 280,751,628 66.8% Founder, Chairman
Citicorp Nominees 46,301,327 11.0% High net worth investors
Monex Boom Securities 45,010,003 10.7% High net worth investors
Fortune Fancy Limited 11,771,260 2.8% High net worth investor
HSBC Custody Nominees 8,543,723 2.0% High net worth investors
Other Shareholders 27,978,703 6.7% Retail Investors
TOTAL 420,356,644 100.0%
For
per
sona
l use
onl
y